MedPath

Manhattan Medical Research Practice, PLLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response

Phase 4
Conditions
Peyronie's Disease
Interventions
First Posted Date
2018-12-06
Last Posted Date
2018-12-07
Lead Sponsor
Manhattan Medical Research Practice, PLLC
Target Recruit Count
20
Registration Number
NCT03767452
Locations
🇺🇸

Manhattan Medical Research Practice, PLLC, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath